Fertility and Sterility
Volume 84, Issue 6 , Pages 1589-1601 , December 2005

A critique of the Women’s Health Initiative hormone therapy study

  • Edward L. Klaiber, M.D.

      Affiliations

    • Department of Internal Medicine, University of Massachusetts Medical Center, Worcester, Massachusetts
    • Corresponding Author InformationReprint requests: Edward L. Klaiber, M.D., 130 Lincoln Street, Worcester, Massachusetts 01605 (FAX: 508-754-5160).
    • ,
  • William Vogel, Ph.D.

      Affiliations

    • Department of Psychiatry, University of Massachusetts Medical Center, Worcester, Massachusetts
    • ,
  • Susan Rako, M.D.

      Affiliations

    • Women’s Health On Alert Inc., Newtonville, Massachusetts

Received 15 November 2004 ,Revised 23 August 2005 ,Accepted 23 August 2005.

References 

  1. Writing Group for the Women’s Health Initiative Investigators . Risks and benefits of estrogen plus progestin in healthy postmenopausal women (principal results from the Women’s Health Initiative randomized controlled trial) . JAMA . 2002;288:321–333
  2. The Women’s Health Initiative Steering Committee . Effects of conjugated equine estrogen in postmenopausal women with hysterectomy (the Women’s Health Initiative randomized controlled trial) . JAMA . 2004;291:1701–1712
  3. Statistics, NCFH . Deaths, percent of total deaths, and death rates for the 10 leading causes of death in selected age groups, by race and sex (United States, 2000–Con) . National Vital Statistics Report . 2002;50:1–85
  4. Stampfer MJ , Willett WC , Colditz GA , Rosner B , Speizer FE , Hennekens CH . A prospective study of postmenopausal estrogen therapy and coronary heart disease . N Engl J Med . 1985;313:1044–1049
  5. Shanes JG , Pavel D , Blend M , Olea E , Krone R , Lacny K , et al.   Comparison of electrocardiography and thallium-201 myocardial scintigraphy for the detection of ergonovine-induced coronary artery spasm (angiographic correlation) . Am Heart J . 1987;113:663–671
  6. Lee GB , Wilson WJ , Amplatz K , Tuna N . Correlation of vectorcardiogram and electrocardiogram with coronary arteriogram . Circulation . 1968;38:189–200
  7. Svedjeholm R , Dahlin LG , Lundberg C , Szabo Z , Kagedal B , Nylander E , et al.   Are electrocardiographic Q-wave criteria reliable for diagnosis of perioperative myocardial infarction after coronary surgery? . Eur J Cardiothorac Surg . 1998;13:655–661
  8. Yamagishi T , Matsuda Y , Satoh A , Ichioka T , Furutani Y , Haraguchi M , et al.   Reliability of the exercise ECG in detecting silent ischemia in patients with prior myocardial infarction . Kaku Igaku . 1991;28:261–269
  9. Breen JF , Sheedy PF , Schwartz RS , Stanson AW , Kaufmann RB , Moll PP , et al.   Coronary artery calcification detected with ultrafast CT as an indication of coronary artery disease . Radiology . 1992;185:435–439
  10. Tanenbaum SR , Kondos GT , Veselik KE , Prendergast MR , Brundage BH , Chomka EV . Detection of calcific deposits in coronary arteries by ultrafast computed tomography and correlation with angiography . Am J Cardiol . 1989;63:870–872
  11. Raggi P , Callister TQ , Cooil B , He ZX , Lippolis NJ , Russo DJ , et al.   Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography . Circulation . 2000;101:850–855
  12. Merino A , Cohen M , Badimon JJ , Fuster V , Badimon L , et al.   Synergistic action of severe wall injury and shear forces on thrombus formation in arterial stenosis (definition of a thrombotic shear rate threshold) . J Am Coll Cardiol . 1994;24:1091–1097
  13. Barstad RM , Orvim U , Hamers MJ , Tjonnfjord GE , Brosstad FR , Sakariassen KS , et al.   Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood flow . Thromb Haemost . 1996;75:827–832
  14. Inauen W , Stocker G , Haeberli A , Straub PW . Effects of low and high dose oral contraceptives on blood coagulation and thrombogenesis induced by vascular subendothelium exposed to flowing human blood . Contraception . 1991;43:435–446
  15. Vehkavaara S , Silveira A , Hakala-Ala-Pietila T , Virkamaki A , Hovatta O , Hamsten A , et al.   Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women . Thromb Haemost . 2001;85:619–625
  16. Hulley S , Grady D , Bush T , Furberg C , Herrington D , Riggs B , et al.  Heart and Estrogen/progestin Replacement Study (HERS) Research Group   Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women . [see comments] JAMA . 1998;280:605–613
  17. Goodman N , Goldzieher J , Ayala C . Critique of the Report from the Writing Group of the WHI . Menopausal Med . 2003;10:1–4
  18. Karas R , Clarkson T . Considerations in interpreting the cardiovascular effects of hormone replacement therapy observed in the WHI (timing is everything) . Menopausal Med . 2003;10:8–12
  19. Lemay A . The relevance of the Women’s Health Initiative results on combined hormone replacement therapy in clinical practice . J Obstet Gynaecol Can . 2002;24:711–715
  20. Herrington DM , Espeland MA , Crouse JR , Robertson J , Riley WA , McBurnie MA , et al.   Estrogen replacement and brachial artery flow-mediated vasodilation in older women . Arterioscler Thromb Vasc Biol . 2001;21:1955–1961
  21. Hodis HN , Mack WJ , Lobo RA , Shoupe D , Sevanian A , Mahrer PR , et al.   Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial . Ann Intern Med . 2001;135:939–953
  22. Mikkola TS , Clarkson TB . Estrogen replacement therapy, atherosclerosis, and vascular function . Cardiovasc Res . 2002;53:605–619
  23. Sueblinvong T , Taechakraichana N , Phupong V . Prevalence of climacteric symptoms according to years after menopause . J Med Assoc Thai . 2001;84:1681–1691
  24. Brett KM , Reuben CA . Prevalence of estrogen or estrogen–progestin hormone therapy use . Obstet Gynecol . 2003;102:1240–1249
  25. Lobo RA . Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women (results from 2 large clinical trials) . Arch Intern Med . 2004;164:482–484
  26. Naftolin F , Taylor HS , Karas R , Brinton E , Newman I , Clarkson TB , et al.   The Women’s Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition . Fertil Steril . 2004;81:1498–1501
  27. Hendrix SL , Prentice RL . WHI Response to Goodman, Goldzieher and Ayala’s critique of the Women’s Health Initiative Report on the risks and benefits of estrogen plus progestin . Menopausal Med . 2003;11:1–3
  28. Mendelsohn ME , Karas RH . The time has come to stop letting the HERS tale wag the dogma . Circulation . 2001;104:2256–2259
  29. Stampfer MJ , Colditz GA . Estrogen replacement therapy and coronary heart disease (a quantitative assessment of the epidemiologic evidence) . Prev Med . 1991;20:47–63
  30. Folsom AR , Mink PJ , Sellers TA , Hong CP , Zheng W , Potter JD . Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women . Am J Public Health . 1995;85:1128–1132
  31. Grodstein F , Stampfer MJ , Manson JE , Colditz GA , Willet WC , Rosner B , et al.   Postmenopausal estrogen and progestin use and the risk of cardiovascular disease . N Engl J Med . 1996;335:453–461
  32. Grodstein F , Manson JE , Colditz GA , Willett WC , Speizer FE , Stampfer MJ . A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease . Ann Intern Med . 2000;133:933–941
  33. Paganini-Hill A , Ross RK , Henderson BE . Postmenopausal oestrogen treatment and stroke (a prospective study) . BMJ . 1988;297:519–522
  34. Paganini-Hill A . Estrogen replacement therapy and stroke . Prog Cardiovasc Dis . 1995;38:223–242
  35. Hunt K , Vessey M , McPherson K . Mortality in a cohort of long-term users of hormone replacement therapy (an updated analysis) . Br J Obstet Gynaecol . 1990;97:1080–1086
  36. Walsh BW , Schiff I , Rosner B , Greenberg L , Ravnikar V , Sacks FM . Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins . N Engl J Med . 1991;325:1196–1204
  37. Kuhl H . Prevention of atherosclerosis by estrogen substitution? . Geburtshilfe Frauenheilkd . 1988;48:747–756
  38. Bush TL , Barrett-Connor E , Cowan LD , Criqui MH , Wallace RB , Suchindran CM , et al.   Cardiovascular mortality and noncontraceptive use of estrogen in women (results from the Lipid Research Clinics Program Follow-up Study) . Circulation . 1987;75:1102–1109
  39. Angerer P , Stork S , Kothny W , von Schacky C . Effect of postmenopausal hormone replacement on atherosclerosis in femoral arteries . Maturitas . 2002;41:51–60
  40. Christian RC , Harrington S , Edwards WD , Oberg AL , Fitzpatrick LA . Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women . J Clin Endocrinol Metab . 2002;87:1062–1067
  41. Hodis HN , Mack WJ . Atherosclerosis imaging methods (assessing cardiovascular disease and evaluating the role of estrogen in the prevention of atherosclerosis) . Am J Cardiol . 2002;89:19E–27E
  42. Stampfer MJ , Colditz GA . Estrogen replacement therapy and coronary heart disease (a quantitative assessment of the epidemiologic evidence) . Prev Med . 1991;20:47–63
  43. Grodstein F , Clarkson TB , Manson JE . Understanding the divergent data on postmenopausal hormone therapy . N Engl J Med . 2003;348:645–650
  44. The Writing Group for the PEPI Trial . Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial . JAMA . 1995;273:199–208
  45. Stefanick ML . Estrogen, progestogens and cardiovascular risk . J Reprod Med . 1999;44:221–226
  46. Sitruk-Ware R . Progestins and cardiovascular risk markers . Steroids . 2000;65:651–658
  47. Rijpkema AH , van der Sanden AA , Ruijs AH . Effects of post-menopausal oestrogen–progestogen replacement therapy on serum lipids and lipoproteins (a review) . Maturitas . 1990;12:259–285
  48. Di Carlo F , Racca S , Conti G , Gallo E , Muccioli G , Sapino A , et al.   Effects of long-term administration of high doses of medroxyprogesterone acetate on hormone receptors and target organs in the female rat . J Endocrinol . 1984;103:287–293
  49. Di Carlo F , Gallo E , Conti G , Racca S . Changes in the binding of oestradiol to uterine oestrogen receptors induced by some progesterone and 19-nor-testosterone derivatives . J Endocrinol . 1983;98:385–389
  50. Bayard F , Damilano S , Robel P , Baulieu EE . Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium . J Clin Endocrinol Metab . 1978;46:635–648
  51. Attardi B . Facilitation and inhibition of the estrogen-induced luteinizing hormone surge in the rat by progesterone (effects on cytoplasmic and nuclear estrogen receptors in the hypothalamus-preoptic area, pituitary, and uterus) . Endocrinology . 1981;108:1487–1496
  52. Sakamoto S , Soh H , Kawasaki T , Okamoto R . Estrogen and progesterone interactions on the estrogen receptor and thymidine kinase in the immature rat uterus . Nippon Sanka Fujinka Gakkai Zasshi . 1982;34:2172–2176
  53. Rall HJ , Soto Ferreira G , Janssens KY . Effect of medroxyprogesterone acetate contraception on cytoplasmic estrogen receptor content of the human cervix uteri . Int J Fertil . 1978;23:51–56
  54. Nilsen J , Brinton RD . Impact of progestins on estradiol potentiation of the glutamate calcium response . Neuroreport . 2002;13:825–830
  55. Shulman LP . Effects of progestins in different hormone replacement therapy formulations on estrogen-induced lipid changes in postmenopausal women . Am J Cardiol . 2002;89:47E–55E
  56. Hemminki E , Sihvo S . A review of postmenopausal hormone therapy recommendations (potential for selection bias) . Obstet Gynecol . 1993;82:1021–1028
  57. Goldman L , Tosteson AN . Uncertainty about postmenopausal estrogen. Time for action, not debate . N Engl J Med . 1991;325:800–802
  58. Gorodeski GI . Impact of the menopause on the epidemiology and risk factors of coronary artery heart disease in women . Exp Gerontol . 1994;29:357–375
  59. Derry PS . Time trends in the HERS secondary prevention trial (much ado about nothing?) . J Am Med Womens Assoc . 2002;57:215–216
  60. The Women’s Health Initiative Study Group . Design of the Women’s Health Initiative clinical trial and observational study . Control Clin Trials . 1998;19:61–109
  61. Grady D , Rubin SM , Petitti DB , Fox CS , Black D , Ettinger B , et al.   Hormone therapy to prevent disease and prolong life in postmenopausal women . Ann Intern Med . 1992;117:1016–1037
  62. Henderson BE , Paganini-Hill A , Ross RK . Decreased mortality in users of estrogen replacement therapy . Arch Intern Med . 1991;151:75–78
  63. Stampfer MJ , Colditz GA , Willett WC , Manson JE , Rosner B , Speizer FE , et al.   Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses’ Health Study . N Engl J Med . 1991;325:756–762
  64. Ettinger B , Friedman GD , Bush T , Quesenberry CP . Reduced mortality associated with long-term postmenopausal estrogen therapy . Obstet Gynecol . 1996;87:6–12
  65. Clarkson TB , Appt SE . MPA and postmenopausal coronary artery atherosclerosis revisited . Steroids . 2003;68:941–951
  66. Psaty BM , Heckbert SR , Atkins D , Siscovick DS , Koepsell TD , Wahl PW , et al.   A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women . Arch Intern Med . 1993;153:1421–1427
  67. Kremer J , de Bruijn HW , Hindriks FR . Serum high density lipoprotein cholesterol levels in women using a contraceptive injection of depot-medroxyprogesterone acetate . Contraception . 1980;22:359–367
  68. Miyagawa K , Rosch J , Stanczyk F , Hermsmeyer K . Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm . Nat Med . 1997;3:324–327
  69. Levine RL , Chen SJ , Durand J , Chen YF , Oparil S . Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery . Circulation . 1996;94:2221–2227
  70. Register TC , Adams MR , Golden DL , Clarkson TB . Conjugated equine estrogens alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys . Arterioscler Thromb Vasc Biol . 1998;18:1164–1171
  71. Clarkson TB . Progestogens and cardiovascular disease. A critical review . J Reprod Med . 1999;44:180–184
  72. Adams MR , Register TC , Golden DL , Wagner JD , Williams JK . Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis . Arterioscler Thromb Vasc Biol . 1997;17:217–221
  73. Clarkson TB , Anthony MS , Wagner JD . A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys . J Clin Endocrinol Metab . 2001;86:5396–5404
  74. Luciano AA , Turksoy RN , Carleo J , Hendrix JW . Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy . Obstet Gynecol . 1998;71:39–43
  75. Adams MR , Kaplan JR , Manuck SB , Koritnik DR , Parks JS , Wolfe MS , et al.   Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone . Arteriosclerosis . 1990;10:1051–1057
  76. Hodis HN , Mack WJ , Azen SP , Lobo RA , Shoupe D , Mahrer PR , et al.   Hormone therapy and the progression of coronary-artery athersclerosis in postmenopausal women . N Engl J Med . 2003;349:535–545
  77. Herrington DM , Reboussin DM , Brosnihan KB , Sharp PC , Shumaker SA , Snyder TE , et al.   Effects of estrogen replacement on the progression of coronary-artery atherosclerosis . N Engl J Med . 2000;343:522–529
  78. Sonoda M , Yonekura K , Yokoyama I , Takenaka K , Nagai R , Aoyagi T . Common carotid intima–media thickness is correlated with myocardial flow reserve in patients with coronary artery disease (a useful non-invasive indicator of coronary atherosclerosis) . Int J Cardiol . 2004;93:131–136
  79. Byington RP , Furberg CD , Herrington DM , Herd JA , Hunninghake D , Lowery M , et al.   Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease (HERS B-mode substudy) . Arterioscler Thromb Vasc Biol . 2002;22:1692–1697
  80. Manson JE , Hsia J , Johnson KC , Rossouw JE , Assaf AR , Lasser NL , et al.   Estrogen plus progestin and the risk of coronary heart disease . N Engl J Med . 2003;349:523–534
  81. Kelly PT . WHI study (one year later) . [letter] San Francisco Med . 2003;19–21
  82. Cline JM , Soderqvist G , von Schoultz E , Skoog L , von Schoultz B . Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques . Am J Obstet Gynecol . 1996;174:93–100
  83. Pike MC , Ross RK . Progestins and menopause (epidemiological studies of risks of endometrial and breast cancer) . Steroids . 2000;65:659–664
  84. Schairer C , Lubin J , Troisi R , Sturgeon S , Brinton L , Hoover R . Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk . [see comments] JAMA . 2000;283:485–491
  85. Colditz GA , Stampfer MJ , Willett WC , Hennekens CH , Rosner B , Speizer FE . Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women . JAMA . 1990;264:2648–2653
  86. Palmer JR , Rosenberg L , Clarke EA , Miller DR , Shapiro S . Breast cancer risk after estrogen replacement therapy (results from the Toronto Breast Cancer Study) . Am J Epidemiol . 1991;134:1386–1401
  87. Collaborative Group on Hormonal Factors in Breast Cancer . Breast cancer and hormone replacement therapy (collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer) . Lancet . 1997;350:1047–1059
  88. Weiss LK , Burkman RT , Cushing-Haugen KL , Voigt LF , Simon MS , Daling JR , et al.   Hormone replacement therapy regimens and breast cancer risk . Obstet Gynecol . 2002;100:1148–1158
  89. Ross RK , Paganini-Hill A , Wan PC , Pike MC . Effect of hormone replacement therapy on breast cancer risk (estrogen versus estrogen plus progestin) . J Natl Cancer Inst . 2000;92:328–332
  90. Beral V  Million Women Study Collaborators . Breast cancer and hormone-replacement therapy in the Million Women Study . Lancet . 2003;362:419–427
  91. Grodstein F , Stampfer MJ , Colditz GA , Willett WC , Manson JE , Joffe M , et al.   Postmenopausal hormone therapy and mortality . [see comments] N Engl J Med . 1997;336:1769–1775
  92. Cheek J , Lacy J , Toth-Fejel S , Morris K , Calhoun K , Pommier RF . The impact of hormone replacement therapy on the detection and stage of breast cancer . Arch Surg . 2002;137:1015–1021
  93. Speroff L . The Million Women Study and breast cancer . Maturitas . 2003;46:1–6
  94. Kelly PT . Assess your true risk of breast cancer . New York: Henry Holt; 2000;
  95. Klaiber EL , Broverman DM , Vogel W , Peterson LG , Snyder MB , et al.   Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy . Psychoneuroendocrinology . 1997;22:549–558
  96. Klaiber EL . Hormones and the mind (a woman’s guide to enhancing mood, memory, and sexual vitality) . New York: HarperCollins; 2001;
  97. Fletcher SW , Colditz GA . Failure of estrogen plus progestin therapy for prevention . JAMA . 2002;288:366–368
  98. Bush TL . Preserving cardiovascular benefits of hormone replacement therapy . J Reprod Med . 2000;45(3 Suppl):259–273
  99. Wagner JD , Clarkson TB , St Clair RW , Schwenke DC , Shively CA , Adams MR . Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys . J Clin Invest . 1991;88:1995–2002
  100. Kuttenn F , Gerson M . Hormone replacement therapy of menopause, heart and blood vessels . Arch Mal Coeur Vaiss . 2001;94:685–689
  101. Rosano GM , Webb CM , Chierchia S , Morgani GL , Gabraele M , Sarrel PM , et al.   Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women . J Am Coll Cardiol . 2000;36:2154–2159
  102. Decensi A , Omodei U , Robertson C , Bonanni B , Guerrieri-Gonzaga A , Ramazzotto F , et al.   Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women . Circulation . 2002;106:1224–1228
  103. Post MS , van der Mooren MJ , Stehouwer CD , van Baal WM , Mijatovic V , Schalkwijk CG , et al.   Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women (a randomised, placebo-controlled trial) . Thromb Haemost . 2002;88:605–610
  104. Vongpatanasin W , Tuncel M , Wang Z , Arbique D , Mehrad B , Jialal I . Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women . J Am Coll Cardiol . 2003;41:1358–1363
  105. Lacut K , Oger E , Le Gal G , Blouch MT , Abgrall JF , Kerlan V , et al.   Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein . Thromb Haemost . 2003;90:124–131
  106. Pradhan AD , Manson JE , Rossouw JE , Siscovick DS , Mouton CP , Rifai N , et al.   Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease (prospective analysis from the Women’s Health Initiative observational study) . JAMA . 2002;288:980–987
  107. Scarabin PY , Oger E , Plu-Bureau G  Estrogen and ThromboEmbolism Risk Study Group . Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk . Lancet . 2003;362:428–432
  108. Schoultz BV . Hormone replacement therapy (standardized or individually adapter doses?) . New York: Parthenon Publishing Group; 1994;
  109. Lindsay R . The menopause and osteoporosis . Obstet Gynecol . 1996;87:16S–19S

PII: S0015-0282(05)03422-9

doi: 10.1016/j.fertnstert.2005.08.010

Fertility and Sterility
Volume 84, Issue 6 , Pages 1589-1601 , December 2005

Article Tools

* Image Usage & Resolution